Table 3.
Percentages of genotypes in individual SNPs for post hoc comparisons of MMP-1, MMP-3, and MMP-9 within MI- and CAD-defined groups.
| MMP | MI | no MI (p-value*) | CAD | no CAD (p-value*) |
|---|---|---|---|---|
| MMP-1 | ||||
| 2G2G | 22% | 23% (-----)† | 21% | 26% (-----)† |
| 2G1G | 50% | 50% (0.56) | 52% | 46% (<0.001) |
| 1G1G | 28% | 27% (0.47) | 26% | 28% (0.22) |
| MMP-3 | ||||
| 6A6A | 24% | 25% (-----)† | 23% | 27% (-----)† |
| 6A5A | 52% | 50% (0.45) | 50% | 48% (0.033) |
| 5A5A | 24% | 26% (0.65) | 27% | 24% (0.012) |
| MMP-9 C-1562T | ||||
| CC | 72% | 75% (-----)† | 75% | 74% (-----)† |
| CT | 26% | 24% (0.06) | 23% | 24% (0.54) |
| TT | 2.1% | 1.6% (0.19) | 2% | 2% (0.89) |
| MMP-9 R279Q | ||||
| RR | 40% | 43% (-----)† | 43% | 42% (-----)† |
| RQ | 47% | 44% (0.026) | 44% | 44% (0.58) |
| 14% | 13% (0.33) | 13% | 14% (0.30) | |
*
Unadjusted;
†
Referent.